Parents are on the verge of having a second option to vaccinate older children after an outside adviser at the Centers for Disease Control and Prevention unanimously recommended clearing Moderna’s two-shot on Thursday. coronavirus Vaccine for children from 6 to 17 years old.
The Pfizer-BioNTech vaccine is already on the market for children aged 5 to 17 years and is intended for children under the age of 12. From November..
The CDC’s Immunization Implementation Advisory Board voted 15-0 at a meeting on Thursday in favor of the Modana Regimen for children. Concerns raised by committee members were primarily related to the language of vaccine vials. They urged Moderna to simplify the wording so as not to confuse the people who manage the shots.
Experts do not expect the new Moderna option to increase low pediatric vaccination rates. Less than one-third of children aged 6 to 11 received two Pfizer-BioNTech shots.Authorities quoted April Investigation According to the Kaiser Family Foundation, about one-third of parents of children over the age of 5 do not plan to vaccinate.
CDC staff Presented data Vaccinated children may develop serious illness to an advisory board showing that more than 10 million children between the ages of 5 and 17 have been infected with the coronavirus and more than 600 have died. Is said to be low.
Moderna told an advisor to the Food and Drug Administration last week For every 1 million doses of vaccine distributed in the United States, 95 hospitalizations and 24 intensive care unit stays for children aged 6 to 11 years are avoided. The company estimates that children between the ages of 12 and 17 will avoid 200 hospitalizations and 52 ICU stays.
Moderna conducted clinical trials For adolescent vaccines before the emergence of Omicron variants. Experts have expressed concern that the data may be unreliable given how Omicron avoids other vaccines, but convinced that Moderna’s shots still prevent serious illness. I have stated.
Regulators have determined that the Moderna vaccine does not cause serious side effects.
Last year, Moderna’s request to approve a vaccine for adolescents was postponed after concerns about the risk of rare heart side effects, including myocarditis.No cases of myocarditis have been reported in the adolescent Moderna trial, but experts said the trial was not large enough to be ruled out as potential. Side effects.
Nonetheless, CDC officials said profits outweigh risks. They stated that the risk of myocarditis could be further reduced by giving a second dose 8 weeks after the first dose, rather than the 4-8 week interval recommended for most adults. According to a Canadian study, wider shot intervals are less likely to cause side effects.
Moderna is also testing boosters for children ages 6-17 and will request approval as early as July.Regulators already Approve the third shot That age group of Pfizer-BioNTech vaccines.
June was an important month for pediatric vaccines. Walensky approved the Moderna and Pfizer-BioNTech vaccines for children under the age of five on Saturday, allowing the youngest Americans to begin firing this week.
Laurie McGinley contributed to this report.
The mention sources can contact us to remove/changing this article
What Are The Main Benefits Of Comparing Car Insurance Quotes Online
to request, modification Contact us at Here or [email protected]
- Israeli fire likely killed Shireen Abu Akleh, but bullet test inconclusive, US says July 4, 2022
- Bollywood never disappoints by ruining hit songs again and again!! July 4, 2022
- Trump rips Liz Cheney after suggesting January 6 charges July 4, 2022
- Folding smartphone got a handy upgrade from Google July 4, 2022
- What good fashion entails July 4, 2022